Related Experiment Video
Updated: Jun 19, 2026

Murine Model of CD40-activation of B cells
Published on: March 5, 2010
The CD40-CD154 co-stimulation pathway mediates innate immune injury in adriamycin nephrosis
Vincent W S Lee1, Xiaohong Qin, Yiping Wang
1Centre for Transplant and Renal Research, Westmead Millennium Institute, University of Sydney at Westmead Hospital, NSW, Australia. vincent_lee@wmi.usyd.edu.au
Background:
Blockade of CD40-CD40 ligand (CD154) interactions protects against renal injury in adriamycin nephropathy (AN) in immunocompetent mice. To investigate whether this protection relied on adaptive or cognate immunity, we tested the effect of CD40-CD154 blockade in severe combined immunodeficient (SCID) mice.
Methods:
SCID mice were divided into three groups: normal, AN + hamster IgG (ADR+IgG group) and AN + anti-CD154 antibody (MR1) (ADR+MR1 group). AN was induced by tail vein injection of 5.2 mg/kg of adriamycin (ADR). Hamster IgG (control Ab) or MR1 was administered intraperitoneally on days 5, 7, 9 and 11 after ADR injection. Histological and functional data were collected 4 weeks after ADR injection. In vitro experiments tested the effect of soluble and cell-bound CD154 co-cultured with CD40-expressing cells [macrophages, mesangial cells and renal tubular epithelial cells (RTEC)].
Results:
All experimental animals developed nephropathy. Compared to the ADR+IgG group, ADR+MR1 animals had significantly less histological injury (glomerulosclerosis and tubular atrophy) and functional injury (creatinine clearance). Kidneys of ADR+MR1 animals had significantly less macrophage infiltration than those of ADR+IgG animals. Interestingly, expression of CD40 and CD41 (a platelet-specific marker) was significantly less in ADR+MR1 animals compared to ADR+IgG animals. In vitro, CD154 blockade significantly attenuated upregulation of CCL2 gene expression by RTEC stimulated by activated macrophage-conditioned medium. In contrast, platelet-induced upregulation of macrophage and mesangial cell proinflammatory cytokine gene expression were not CD154-dependent.
Conclusion:
CD40-CD154 blockade has a significant innate renoprotective effect in ADR nephrosis. This is potentially due to inhibition of macrophage-derived soluble CD154.
Insights
CD40-CD154 blockade offers innate protection against adriamycin-induced kidney injury in mice, even without adaptive immunity. This effect may stem from reduced macrophage infiltration and inflammatory responses.
Area of Science:
- Immunology
- Nephrology
- Pharmacology
Background:
- CD40-CD154 blockade previously showed renal protection in adriamycin nephropathy (AN) in immunocompetent mice.
- The role of adaptive versus innate immunity in this protection was unclear.
- This study investigated CD40-CD154 blockade in severe combined immunodeficient (SCID) mice to elucidate the immune mechanisms involved.
Purpose of the Study:
- To determine if CD40-CD154 blockade protects against adriamycin nephropathy (AN) in SCID mice, which lack adaptive immunity.
- To investigate the innate immune mechanisms underlying the renoprotective effects of CD40-CD154 blockade.
- To assess the impact of CD40-CD154 blockade on macrophage infiltration and inflammatory gene expression in the kidney.
Main Methods:
- SCID mice were induced with adriamycin (ADR) and treated with either control IgG or anti-CD154 antibody (MR1).
- Renal function and histology were assessed four weeks post-ADR injection.
- In vitro studies examined the effect of CD154 blockade on CD40-expressing renal cells (macrophages, mesangial cells, RTEC) and platelet-induced inflammation.
Main Results:
- ADR-induced nephropathy occurred in all groups; however, MR1 treatment significantly reduced histological and functional renal injury compared to controls.
- MR1 treatment led to decreased macrophage infiltration in the kidneys.
- In vitro, CD154 blockade attenuated CCL2 gene expression in RTEC stimulated by macrophages, but did not affect platelet-induced cytokine expression.
Conclusions:
- CD40-CD154 blockade confers a significant innate renoprotective effect in adriamycin nephrosis.
- This protection is likely mediated by the inhibition of macrophage-derived soluble CD154, independent of adaptive immunity.
- The findings highlight the potential of targeting the CD40-CD154 pathway for treating kidney diseases involving innate immune responses.
More Related Videos
Related Concept Videos
Cytotoxic Edema: Pathophysiology
Intracellular Signaling Affects Focal Adhesions
Some...
The Intrinsic Apoptotic Pathway
The Extrinsic Apoptotic Pathway
Cytotoxic T Cells-mediated Immune Response
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Cell-mediated Immune Responses

